Adeel A Butt

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. pmc Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study
    Adeel A Butt
    University of Pittsburgh School of Medicine, PA 15213, USA
    Clin Infect Dis 55:631-8. 2012
  2. doi Boceprevir and telaprevir in the management of hepatitis C virus-infected patients
    Adeel A Butt
    Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Clin Infect Dis 54:96-104. 2012
  3. pmc Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease
    Adeel A Butt
    Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Arch Intern Med 171:737-43. 2011
  4. pmc A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans
    Adeel A Butt
    University of Pittsburgh School of Medicine, Pennsylvania, USA
    AIDS Res Hum Retroviruses 27:973-9. 2011
  5. pmc The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin
    A A Butt
    Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, 3601 Fifth Avenue, Pittsburgh, PA 15213, USA
    Aliment Pharmacol Ther 33:1234-44. 2011
  6. doi HIV infection and the risk of acute myocardial infarction
    Matthew S Freiberg
    University of Pittsburgh School ofMedicine, Pittsburgh, PA 15213, USA
    JAMA Intern Med 173:614-22. 2013
  7. pmc The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C
    Matthew S Freiberg
    University of Pittsburgh School of Medicine, 230 McKee Place, Pittsburgh, PA 15213, USA
    Circ Cardiovasc Qual Outcomes 4:425-32. 2011
  8. pmc Hepatitis C treatment completion rates in routine clinical care
    Adeel A Butt
    Center for Health Equity Research and Promotion, University of Pittsburgh School of Medicine, VA Pittsburgh Healthcare System, Pittsburgh, PA 15213, USA
    Liver Int 30:240-50. 2010
  9. pmc Rates of HCV treatment eligibility among HCV-monoinfected and HCV/HIV-coinfected patients in tertiary care referral centers
    Adeel A Butt
    Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    HIV Clin Trials 10:25-32. 2009
  10. pmc Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study
    Raj K Medapalli
    Department of Medicine, Division of Nephrology, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 60:393-9. 2012

Detail Information

Publications35

  1. pmc Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study
    Adeel A Butt
    University of Pittsburgh School of Medicine, PA 15213, USA
    Clin Infect Dis 55:631-8. 2012
    ..The effect of peginterferon alpha/ribavirin (PEG-IFN/RBV) and hepatitis C virus (HCV) clearance on lipid and insulin resistance (IR) profiles in HCV/human immunodeficiency virus (HIV) coinfection is unknown...
  2. doi Boceprevir and telaprevir in the management of hepatitis C virus-infected patients
    Adeel A Butt
    Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Clin Infect Dis 54:96-104. 2012
    ..As with all drugs, especially newly approved drugs, clinicians must consult the package insert for detailed prescribing information, list of all reported adverse events, contraindications, and drug interactions...
  3. pmc Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease
    Adeel A Butt
    Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Arch Intern Med 171:737-43. 2011
    ..Whether human immunodeficiency virus (HIV) infection is a risk factor for heart failure (HF) is not clear. The presence of coronary heart disease and alcohol consumption in this population may confound this association...
  4. pmc A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans
    Adeel A Butt
    University of Pittsburgh School of Medicine, Pennsylvania, USA
    AIDS Res Hum Retroviruses 27:973-9. 2011
    ..Even for those who are eligible for treatment, only a minority is prescribed treatment. Several contraindications are modifiable and aggressive management of those may improve treatment prescription rates...
  5. pmc The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin
    A A Butt
    Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, 3601 Fifth Avenue, Pittsburgh, PA 15213, USA
    Aliment Pharmacol Ther 33:1234-44. 2011
    ..The association of anaemia with outcomes in the HCV/HIV coinfected persons undergoing HCV treatment remains unclear...
  6. doi HIV infection and the risk of acute myocardial infarction
    Matthew S Freiberg
    University of Pittsburgh School ofMedicine, Pittsburgh, PA 15213, USA
    JAMA Intern Med 173:614-22. 2013
    ....
  7. pmc The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C
    Matthew S Freiberg
    University of Pittsburgh School of Medicine, 230 McKee Place, Pittsburgh, PA 15213, USA
    Circ Cardiovasc Qual Outcomes 4:425-32. 2011
    ....
  8. pmc Hepatitis C treatment completion rates in routine clinical care
    Adeel A Butt
    Center for Health Equity Research and Promotion, University of Pittsburgh School of Medicine, VA Pittsburgh Healthcare System, Pittsburgh, PA 15213, USA
    Liver Int 30:240-50. 2010
    ..Treatment completion rates for hepatitis C virus (HCV) infection in clinical practice settings are unknown...
  9. pmc Rates of HCV treatment eligibility among HCV-monoinfected and HCV/HIV-coinfected patients in tertiary care referral centers
    Adeel A Butt
    Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    HIV Clin Trials 10:25-32. 2009
    ..Treatment eligibility rates in patients with HCV monoinfection have not been directly compared with patients with HCV/HIV coinfection. These data are important for planning interventions to optimize HCV management...
  10. pmc Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study
    Raj K Medapalli
    Department of Medicine, Division of Nephrology, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 60:393-9. 2012
    ..Studies suggest that HIV and diabetes have an additive effect on chronic kidney disease (CKD) progression; however, this observation may be confounded by differences in traditional CKD risk factors...
  11. pmc The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medication
    Matthew S Freiberg
    University of Pittsburgh, Center for Research on Health Care, Pittsburgh, PA, USA
    J Gen Intern Med 24:334-40. 2009
    ....
  12. pmc Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source
    Kathleen A McGinnis
    Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, 7180 Highland Drive 151C H, Pittsburgh, PA 15206 4900, USA
    Nicotine Tob Res 13:1233-9. 2011
    ..We assessed smoking data from the Veterans Health Administration (VHA) electronic medical record (EMR) Health Factors dataset...
  13. pmc HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era
    Kristina Crothers
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine, Harborview Medical Center, Seattle, WA 98104, USA
    Am J Respir Crit Care Med 183:388-95. 2011
    ..In aging HIV-infected populations comorbid diseases are important determinants of morbidity and mortality. Pulmonary diseases have not been systematically assessed in the combination antiretroviral therapy (ART) era...
  14. pmc HIV infection and the risk of diabetes mellitus
    Adeel A Butt
    University of Pittsburgh School of Medicine, VA Pittsburgh Healthcare System, Pennsylvania, USA
    AIDS 23:1227-34. 2009
    ..The influence of HIV infection on the risk of diabetes is unclear. We determined the association and predictors of prevalent diabetes mellitus in HIV infected and uninfected veterans...
  15. ncbi Comorbidities and their impact on mortality in HCV and HCV-HIV-coinfected persons on dialysis
    Adeel A Butt
    University of Pittsburgh Medical Center, Pittsburgh, PA 15213
    J Clin Gastroenterol 42:1054-59. 2008
    ..To determine the rates of non-human immuno deficiency virus (HIV)-related comorbidities and their impact on survival in hepatitis C virus (HCV) and HCV-HIV coinfected persons on dialysis...
  16. pmc HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation
    Kaku A Armah
    Graduate School of Public Health, Department of Epidemiology, University of Pittsburgh, PA, USA
    Clin Infect Dis 55:126-36. 2012
    ..We compared biomarkers for inflammation, altered coagulation, and monocyte activation between HIV-infected and uninfected people in the Veterans Aging Cohort Study (VACS)...
  17. ncbi Biochemical and virologic parameters in patients co-infected with hepatitis C and HIV versus patients with hepatitis C mono-infection
    Adeel A Butt
    Division of Infectious Diseases, University of Pittsburgh Medical Center, VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion, Pittsburgh, Pennsylvania 15213, USA
    Am J Med Sci 333:271-5. 2007
    ..Accurate characterization of the effect of HIV is important for evaluation and treatment of HCV in co-infected persons...
  18. ncbi Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection
    Adeel A Butt
    Division of Infectious Diseases, University of Pittsburgh School of Medicine, and VA Pittsburgh Healthcare System, PA, USA
    Hepatology 40:115-9. 2004
    ..HCV coinfection is associated with a significantly higher risk of diabetes in the HAART era, but not in the pre-HAART era. HCV-HIV coinfected patients should be aggressively screened for diabetes...
  19. ncbi Hepatitis C virus infection: the new global epidemic
    Adeel A Butt
    University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Expert Rev Anti Infect Ther 3:241-9. 2005
    ..Since treatment is expensive and associated with significant adverse effects, more effective strategies for the prevention of transmission are needed, especially in resource-limited countries, where the burden of disease is the highest...
  20. pmc Rate and predictors of treatment prescription for hepatitis C
    Adeel A Butt
    University of Pittsburgh Medical Center, Falk Medical Building, Pittsburgh, PA 15213, USA
    Gut 56:385-9. 2007
    ..The true treatment rate for hepatitis C virus (HCV) in veterans is unknown...
  21. doi Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia
    Arpan Mohanty
    Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    Clin Gastroenterol Hepatol 11:741-7.e3. 2013
    ..However, among those who are treated for HCV infection, the effect of treatment on mortality is not clear...
  22. pmc Effect of race and HIV co-infection upon treatment prescription for hepatitis C virus
    Adeel A Butt
    Division of Infectious Diseases, 3601 Fifth Avenue, Suite 3A, Falk Medical Building, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Int J Infect Dis 13:449-55. 2009
    ..Treatment rates for hepatitis C virus (HCV) have not been compared directly between HCV mono-infected and HCV-HIV co-infected patients in academic center settings...
  23. pmc Hepatitis C virus infection and the risk of coronary disease
    Adeel A Butt
    VA Pittsburgh Healthcare System, University of Pittsburgh School of Medicine, Center for Health Equity Research and Promotion, Pittsburgh, Pennsylvania, USA
    Clin Infect Dis 49:225-32. 2009
    ..The association between hepatitis C virus (HCV) infection and coronary artery disease (CAD) is controversial. We conducted this study to determine and quantify this association...
  24. pmc Decreased serum antibody responses to recombinant pneumocystis antigens in HIV-infected and uninfected current smokers
    Kristina Crothers
    University of Washington School of Medicine, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, 325 Ninth Avenue, Box 359762, Seattle, WA 98104, USA
    Clin Vaccine Immunol 18:380-6. 2011
    ..Whether smoking exerts an immunosuppressive effect that affects the P. jirovecii antibody response, colonization, or subsequent risk for disease is unclear; prospective, longitudinal studies are needed to evaluate these findings further...
  25. ncbi Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy
    Adeel A Butt
    University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    AIDS Read 13:344-8. 2003
    ..Extreme caution should be exercised when didanosine and ribavirin are used concomitantly because of the increased risk of mitochondrial toxicity and the syndrome of severe metabolic acidosis with elevated lactic acid levels...
  26. doi HCV infection and the incidence of CKD
    Adeel A Butt
    University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Am J Kidney Dis 57:396-402. 2011
    ..The risk of hepatitis C virus (HCV) infection upon incident chronic kidney disease (CKD) in the presence of traditional risk factors and renal-modifying therapy is not well known...
  27. ncbi Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection
    Shawn L Fultz
    Center for Health Equity Research and Promotion, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    Clin Infect Dis 36:1039-46. 2003
    ..Health care providers are often unaware of alcohol consumption that may accelerate the course of hepatitis C, increase the risk of hepatocellular carcinoma, and reduce treatment efficacy...
  28. ncbi Hepatitis C information on the world wide web
    Adeel A Butt
    Division of Infectious Diseases, University of Pittsburgh, VA Pittsburgh Healthcare System and Center for Health Equity Research and Promotion, Pittsburgh, PA, 15213, USA
    Clin Infect Dis 35:754-9. 2002
    ..This review provides an overview of selected Web sites for health care providers and researchers, sites of professional societies, sites created by patients, and sites created by the pharmaceutical industry...
  29. ncbi Infections related to the ingestion of seafood. Part II: parasitic infections and food safety
    Adeel A Butt
    Division of Infectious Diseases, University of Pittsburgh, VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion, Pittsburgh, PA 15213, USA
    Lancet Infect Dis 4:294-300. 2004
    ..Consumers should take common precautions including obtaining seafood from reputable sources especially if the seafood is to be consumed uncooked. Adequate cooking of seafood is the safest way of preventing related infections...
  30. ncbi The association of serum lactate dehydrogenase level with selected opportunistic infections and HIV progression
    Adeel A Butt
    Louisiana State University Health Sciences Center, New Orleans, USA
    Int J Infect Dis 6:178-81. 2002
    ..The purpose of this study was to determine the association of serum lactate dehydrogenase (LDH) levels with certain opportunistic infection and to determine an association between LDH levels and CD4+ lymphocyte counts...
  31. ncbi Infections related to the ingestion of seafood Part I: Viral and bacterial infections
    Adeel A Butt
    Division of Infectious Diseases, University of Pittsburgh, the VA Pittsburgh Healthcare System, and The Center for Health Equity Research and Promotion, Pittsburgh, PA 15213, USA
    Lancet Infect Dis 4:201-12. 2004
    ..In the May issue of the journal we will discuss parasites associated with seafood consumption, the safety of seafood, and the measures put in place in the USA to increase its safety...
  32. ncbi Effect of hepatitis C virus and its treatment on survival
    Adeel A Butt
    University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Hepatology 50:387-92. 2009
    ..Further studies are warranted to determine the effect of virological control on survival...
  33. ncbi Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis
    Adeel A Butt
    University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    J Hepatol 44:864-8. 2006
    ..The burden of comorbidity in the Hepatitis C virus (HCV) infected persons on dialysis is unknown...
  34. ncbi Tenofovir for chronic hepatitis B virus infection in HIV-coinfected patients
    Adeel A Butt
    University of Pittsburgh School of Medicine, Division of Infectious Diseases, Center for Health Equity Research and Promotion, USA
    AIDS Read 16:219-22. 2006
    ..14-log10 decrease in HIV RNA level at 36 months of follow-up. The CD4+ lymphocyte count increased by a mean (median) value of 47/microL (177/microL). No significant adverse events attributable to tenofovir therapy were reported...
  35. ncbi Serum LDH level as a clue to the diagnosis of histoplasmosis
    Adeel A Butt
    University of Pittsburgh, ID HIV Clinics, Pittsburgh VA Healthcare System, Pittsburgh, USA
    AIDS Read 12:317-21. 2002
    ..Serum LDH may serve as an adjunct laboratory marker in the diagnosis of histoplasmosis. Elevated levels may prompt the physician to look for a diagnosis other than PCP early in the course of the illness...